US8523123052 - Common Stock
STAAR SURGICAL CO
NASDAQ:STAA (11/21/2024, 8:00:01 PM)
After market: 26.63 0 (0%)26.63
+0.31 (+1.18%)
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The company is headquartered in Monrovia California, California and currently employs 1,056 full-time employees. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The firm is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The firm markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The firm also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
STAAR SURGICAL CO
1911 Walker Ave
Monrovia California CALIFORNIA 92630
P: 16263037902
CEO: Caren Mason
Employees: 1057
Website: https://www.staar.com/
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced.
Here you can normally see the latest stock twits on STAA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: